BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19776078)

  • 21. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH; O'Neill C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
    Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
    Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
    Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
    Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
    Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease.
    Yu WH; Kumar A; Peterhoff C; Shapiro Kulnane L; Uchiyama Y; Lamb BT; Cuervo AM; Nixon RA
    Int J Biochem Cell Biol; 2004 Dec; 36(12):2531-40. PubMed ID: 15325590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered β1,6-GlcNAc and bisecting GlcNAc-branched N-glycan on integrin β1 are associated with early spontaneous miscarriage in humans.
    Zhang M; Wang M; Gao R; Liu X; Chen X; Geng Y; Ding Y; Wang Y; He J
    Hum Reprod; 2015 Sep; 30(9):2064-75. PubMed ID: 26109616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
    Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function.
    Kurimoto A; Kitazume S; Kizuka Y; Nakajima K; Oka R; Fujinawa R; Korekane H; Yamaguchi Y; Wada Y; Taniguchi N
    J Biol Chem; 2014 Apr; 289(17):11704-11714. PubMed ID: 24619415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
    Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III.
    Rouwendal GJ; Wuhrer M; Florack DE; Koeleman CA; Deelder AM; Bakker H; Stoopen GM; van Die I; Helsper JP; Hokke CH; Bosch D
    Glycobiology; 2007 Mar; 17(3):334-44. PubMed ID: 17179169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide Sequence Mapping around Bisecting GlcNAc-Bearing
    Ohkawa Y; Kizuka Y; Takata M; Nakano M; Ito E; Mishra SK; Akatsuka H; Harada Y; Taniguchi N
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445285
    [No Abstract]   [Full Text] [Related]  

  • 33. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
    Pan K; Chen S; Wang Y; Yao W; Gao X
    Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
    Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
    Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion.
    Isaji T; Kariya Y; Xu Q; Fukuda T; Taniguchi N; Gu J
    Methods Enzymol; 2010; 480():445-59. PubMed ID: 20816221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.
    Zhao Y; Nakagawa T; Itoh S; Inamori K; Isaji T; Kariya Y; Kondo A; Miyoshi E; Miyazaki K; Kawasaki N; Taniguchi N; Gu J
    J Biol Chem; 2006 Oct; 281(43):32122-30. PubMed ID: 16940045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.
    Kariya Y; Kato R; Itoh S; Fukuda T; Shibukawa Y; Sanzen N; Sekiguchi K; Wada Y; Kawasaki N; Gu J
    J Biol Chem; 2008 Nov; 283(48):33036-45. PubMed ID: 18812317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A catalytically inactive beta 1,4-N-acetylglucosaminyltransferase III (GnT-III) behaves as a dominant negative GnT-III inhibitor.
    Ihara H; Ikeda Y; Koyota S; Endo T; Honke K; Taniguchi N
    Eur J Biochem; 2002 Jan; 269(1):193-201. PubMed ID: 11784313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor.
    Ihara Y; Sakamoto Y; Mihara M; Shimizu K; Taniguchi N
    J Biol Chem; 1997 Apr; 272(15):9629-34. PubMed ID: 9092490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.
    Isaji T; Gu J; Nishiuchi R; Zhao Y; Takahashi M; Miyoshi E; Honke K; Sekiguchi K; Taniguchi N
    J Biol Chem; 2004 May; 279(19):19747-54. PubMed ID: 14998999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.